Bearman SI - Search Results

1

Role of autotransplantation in treatment of other solid tumors.

Shpall EJ, Stemmer SM, Bearman SI, Jones RB. Shpall EJ, et al. Among authors: bearman si. Hematol Oncol Clin North Am. 1993 Jun;7(3):663-86. Hematol Oncol Clin North Am. 1993. PMID: 8344885 Review.

2

Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.

Shpall EJ, Stemmer SM, Johnston CF, Hami L, Bearman SI, Berenson R, Jones RB. Shpall EJ, et al. Among authors: bearman si. J Hematother. 1992 Spring;1(1):45-54. doi: 10.1089/scd.1.1992.1.45. J Hematother. 1992. PMID: 1365017 Review.

3

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, et al. Shpall EJ, et al. Among authors: bearman si. J Clin Oncol. 1994 Jan;12(1):28-36. doi: 10.1200/JCO.1994.12.1.28. J Clin Oncol. 1994. PMID: 7505806

4

New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.

Shpall EJ, Stemmer SM, Bearman SI, Myers S, Purdy M, Jones RB. Shpall EJ, et al. Among authors: bearman si. Breast Cancer Res Treat. 1993;26 Suppl:S19-23. doi: 10.1007/BF00668356. Breast Cancer Res Treat. 1993. PMID: 7691269 Clinical Trial.

5

Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support.

Shpall EJ, Jones RB, Bearman SI, Purdy MP. Shpall EJ, et al. Among authors: bearman si. Gynecol Oncol. 1994 Sep;54(3):357-61. doi: 10.1006/gyno.1994.1223. Gynecol Oncol. 1994. PMID: 8088613 Clinical Trial.

6

Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.

Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC Jr, McCulloch W, et al. Shpall EJ, et al. Among authors: bearman si. Blood. 1994 Jun 1;83(11):3132-7. Blood. 1994. PMID: 8193351 Free article. Clinical Trial.

7

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer.

Jones RB, Matthes S, Dufton C, Bearman SI, Stemmer SM, Meyers S, Shpall EJ. Jones RB, et al. Among authors: bearman si. Breast Cancer Res Treat. 1993;26 Suppl:S11-7. doi: 10.1007/BF00668355. Breast Cancer Res Treat. 1993. PMID: 8400329 Review.

8

Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.

Jones RB, Matthes S, Shpall EJ, Fisher JH, Stemmer SM, Dufton C, Stephens JK, Bearman SI. Jones RB, et al. Among authors: bearman si. J Natl Cancer Inst. 1993 Apr 21;85(8):640-7. doi: 10.1093/jnci/85.8.640. J Natl Cancer Inst. 1993. PMID: 8468721

9

High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.

Bearman SI, Shpall EJ, Jones RB, Cagnoni PJ, Ross M. Bearman SI, et al. Semin Oncol. 1996 Feb;23(1 Suppl 2):60-7. Semin Oncol. 1996. PMID: 8614848 Review.

10

Bone marrow metastases.

Shpall EJ, Gee AP, Hogan C, Cagnoni P, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB. Shpall EJ, et al. Among authors: bearman si. Hematol Oncol Clin North Am. 1996 Apr;10(2):321-43. doi: 10.1016/s0889-8588(05)70341-5. Hematol Oncol Clin North Am. 1996. PMID: 8707758 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters